Centinel Spine, the pioneer of Stand-Alone, No-Profile and Integrated Interbody fusion devices, expands its MIDLINE II-Ti product family with a Ti-ACTIVE coated, No-Profile, anterior lumbar Integrated Interbody device, in the U.S. and Australia.
MIDLINE II-Ti, the most recent Centinel Spine innovation for anterior lumbar interbody fusion (ALIF) procedures, represents the sixth generation of STALIF technology. MIDLINE II-Ti blends the STALIF Integrated Interbody advantage with Ti-ACTIVE, a uniquely texturized, microporous titanium plasma coating, to form a novel technology and approach to ALIF procedures with 8°, 12°, 16° and 20° of lordosis, excellent radiographic visualization and three cancellous screws for optimum stability.
MIDLINE II-Ti is based upon the STALIF MIDLINE II product family. MIDLINE II was designed to offer surgeons increased ease of use by reducing the surgical envelope required to implant the device while maintaining the superior biomechanics that have underpinned thirty years of STALIF surgical success. In harmony with Wolff’s law, three strategically configured cancellous screws create additional compression at each treated segment. The Ti-ACTIVE coating increases the contact surface area and friction at the bony endplates. To date around 1,000 MIDLINE II devices have been implanted.
Centinel Spine also develops, manufactures, markets and sells the complete STALIF product family, which includes STALIF C, STALIF C-TiTM for anterior cervical discectomy fusion procedures and STALIF LTM for lateral lumbar interbody fusion procedures. Recently, Centinel Spine received FDA clearance for ALTOS PCT, a posterior cervical stabilization system specifically designed for use in either the cervical lateral masses or cervical-thoracic pedicles.